PRKCA and lung carcinoma: Overexpression of PKCι has been observed in several human cancers, including gastric (Hashimoto et al., 2019), pancreatic (Scotti et al., 2010), breast (Rosse et al., 2014), ovarian (Tsang et al., 2017), prostate (Apostolatos et al., 2018), and lung cancer (Kim et al., 2019) and has been shown to act as an oncogenic driver in numerous studies (reviewed in Parker et al., 2014).